BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36939332)

  • 1. Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection.
    Wang S; Ju X; Heuler J; Zhang K; Duan Z; Warnakulasuriya Patabendige HML; Zhao S; Sun X
    Infect Immun; 2023 Apr; 91(4):e0016922. PubMed ID: 36939332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
    Wang S; Zhu D; Sun X
    Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of linear epitopes on the flagellar proteins of Clostridioides difficile.
    Razim A; Pacyga K; Naporowski P; Martynowski D; Szuba A; Gamian A; Górska S
    Sci Rep; 2021 May; 11(1):9940. PubMed ID: 33976336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters.
    Dingle TC; Mulvey GL; Armstrong GD
    Infect Immun; 2011 Oct; 79(10):4061-7. PubMed ID: 21788384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.
    Ghose C; Eugenis I; Sun X; Edwards AN; McBride SM; Pride DT; Kelly CP; Ho DD
    Emerg Microbes Infect; 2016 Feb; 5(2):e8. PubMed ID: 26839147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
    Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
    Wang Y; Wang S; Bouillaut L; Li C; Duan Z; Zhang K; Ju X; Tzipori S; Sonenshein AL; Sun X
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30150259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
    Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
    BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.
    Ghose C; Verhagen JM; Chen X; Yu J; Huang Y; Chenesseau O; Kelly CP; Ho DD
    Infect Immun; 2013 Jun; 81(6):2190-6. PubMed ID: 23545305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motility and the genotype diversity of the flagellin genes fliC and fliD among Clostridioides difficile ribotypes.
    Karpiński P; Wultańska D; Piotrowski M; Brajerova M; Mikucka A; Pituch H; Krutova M
    Anaerobe; 2022 Feb; 73():102476. PubMed ID: 34780914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.
    Amadou Amani S; Shadid T; Ballard JD; Lang ML
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico designing of vaccine candidate against Clostridium difficile.
    Basak S; Deb D; Narsaria U; Kar T; Castiglione F; Sanyal I; Bade PD; Srivastava AP
    Sci Rep; 2021 Jul; 11(1):14215. PubMed ID: 34244557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the genes encoding surface associated proteins of Clostridioides difficile isolates.
    Aliramezani A; Talebi M; Douraghi M
    Infect Genet Evol; 2020 Dec; 86():104598. PubMed ID: 33080382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.
    Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H
    Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
    Hong HA; Hitri K; Hosseini S; Kotowicz N; Bryan D; Mawas F; Wilkinson AJ; van Broekhoven A; Kearsey J; Cutting SM
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen
    Bradshaw WJ; Bruxelle JF; Kovacs-Simon A; Harmer NJ; Janoir C; Péchiné S; Acharya KR; Michell SL
    J Biol Chem; 2019 Oct; 294(43):15850-15861. PubMed ID: 31420448
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.